These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 17123702)
1. On the origin of syn- and metachronous urothelial carcinomas. Höglund M Eur Urol; 2007 May; 51(5):1185-93; discussion 1193. PubMed ID: 17123702 [TBL] [Abstract][Full Text] [Related]
2. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743 [TBL] [Abstract][Full Text] [Related]
3. Bladder cancer, a two phased disease? Höglund M Semin Cancer Biol; 2007 Jun; 17(3):225-32. PubMed ID: 16574430 [TBL] [Abstract][Full Text] [Related]
4. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Habuchi T Int J Urol; 2005 Aug; 12(8):709-16. PubMed ID: 16174043 [TBL] [Abstract][Full Text] [Related]
5. [Significance of chromosome 9 alterations as an initial step in urothelial carcinogenesis]. Habuchi T; Kato T; Takahashi T; Ogawa O Hinyokika Kiyo; 2000 Oct; 46(10):749-55. PubMed ID: 11215205 [TBL] [Abstract][Full Text] [Related]
6. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Hafner C; Knuechel R; Stoehr R; Hartmann A Int J Cancer; 2002 Sep; 101(1):1-6. PubMed ID: 12209580 [TBL] [Abstract][Full Text] [Related]
7. Evidence for common clonal origin of multifocal lung cancers. Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924 [TBL] [Abstract][Full Text] [Related]
8. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns. Miyake H; Hara I; Kamidono S; Eto H J Urol; 2004 Sep; 172(3):1127-9. PubMed ID: 15311055 [TBL] [Abstract][Full Text] [Related]
9. Identical clonal origin of synchronous and metachronous low-grade, noninvasive papillary transitional cell carcinomas of the urinary tract. Li M; Cannizzaro LA Hum Pathol; 1999 Oct; 30(10):1197-200. PubMed ID: 10534167 [TBL] [Abstract][Full Text] [Related]
10. Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance. Catto JW; Hartmann A; Stoehr R; Bolderson E; Rehman I; Rosario DJ; Hamdy FC; Meuth M J Urol; 2006 Jun; 175(6):2323-30. PubMed ID: 16697867 [TBL] [Abstract][Full Text] [Related]
11. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
12. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170 [TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer. Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480 [TBL] [Abstract][Full Text] [Related]
14. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932 [TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [TBL] [Abstract][Full Text] [Related]
16. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565 [TBL] [Abstract][Full Text] [Related]
17. The molecular signature for urothelial carcinoma of the upper urinary tract. Ho CL; Tzai TS; Chen JC; Tsai HW; Cheng HL; Eisenberger CF; Chow NH J Urol; 2008 Mar; 179(3):1155-9. PubMed ID: 18206169 [TBL] [Abstract][Full Text] [Related]
18. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Rouprêt M; Yates DR; Comperat E; Cussenot O Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695 [TBL] [Abstract][Full Text] [Related]
19. [Primary upper urinary tract tumors and subsequent location in the bladder]. Azémar MD; Audouin M; Revaux A; Misraï V; Comperat E; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M Prog Urol; 2009 Oct; 19(9):583-8. PubMed ID: 19800544 [TBL] [Abstract][Full Text] [Related]
20. Mutagenic Factors and Complex Clonal Relationship of Multifocal Urothelial Cell Carcinoma. Du Y; Li R; Chen Z; Wang X; Xu T; Bai F Eur Urol; 2017 May; 71(5):841-843. PubMed ID: 27743758 [No Abstract] [Full Text] [Related] [Next] [New Search]